The event showcases early, growth stage and public life science and health technology companies, providing an opportunity to pitch, profile and connect with investors and partners brought together during the biggest week in European life science investment.
The core focus remains to serve as a unique platform for Biotech, Medtech and Healthtech companies to connect with investors, and is the opening day of Jefferies European Life Science Investment week.
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze